BlackRock Institutional Trust’s Celgene Corp CELG Stock Holding History
Bought
Maintained
Sold
Other funds holding CELG
BFA
BlackRock Institutional Trust's CELG Position: Q4 2016 in Review
BlackRock Institutional Trust increased its Celgene Corp (CELG) stake by 2.6% in Q4 2016, buying an estimated $60.2M and bringing the position to 21,253,432 shares worth $2.46B. The position accounts for 0.36% of the portfolio, ranked #46.
BlackRock Institutional Trust first reported a position in CELG in Q2 2013 and has held it in 15 quarters since. 1,375 funds tracked by Wall St. Rank hold CELG as of Q4 2016.
- BlackRock Institutional Trust held 21,253,432 shares of Celgene Corp worth $2.46B as of Q4 2016.
- BlackRock Institutional Trust bought 540,647 Celgene Corp shares in Q4 2016, an estimated $60.2M.
- Celgene Corp made up 0.36% of BlackRock Institutional Trust's portfolio in Q4 2016, its #46 holding.
- BlackRock Institutional Trust first reported a position in Celgene Corp in Q2 2013 and has held it in 15 quarters since.
- 1,375 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2016.
Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.